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Abstract
Pneumonia may be caused by a wide range of pathogens and is considered the most com-
mon infectious cause of death in humans. Murine acute lung infection models mirror human
pathologies in many aspects and contribute to our understanding of the disease and the
development of novel treatment strategies. Despite progress in other fields of tissue imag-
ing, histopathology remains the most conclusive and practical read out tool for the descrip-
tive and semiquantitative evaluation of mouse pneumonia and therapeutic interventions.
Here, we systematically describe and compare the distinctive histopathological features of
established models of acute pneumonia in mice induced by Streptococcus (S.) pneumoniae,
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Legionella pneu-
mophila, Escherichia coli, Middle East respiratory syndrome (MERS) coronavirus, influenza
A virus (IAV) and superinfection of IAV-incuced pneumonia with S. pneumoniae. Systematic
comparisons of the models revealed striking differences in the distribution of lesions, the
characteristics of pneumonia induced, principal inflammatory cell types, lesions in adjacent
tissues, and the detectability of the pathogens in histological sections. We therefore identi-
fied core criteria for each model suitable for practical semiquantitative scoring systems that
take into account the pathogen- and model-specific patterns of pneumonia. Other critical
factors that affect experimental pathologies are discussed, including infectious dose, time
kinetics, and the genetic background of the mouse strain. The substantial differences
between the model-specific pathologies underscore the necessity of pathogen- and model-
adapted criteria for the comparative quantification of experimental outcomes. These criteria
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Introduction
As one of the most frequent infectious diseases, pneumonia causes a tremendous socioeco-
nomic burden in industrialized countries [1] and is the leading infectious cause of death in
children worldwide [2]. Numerous classes of pathogens can cause acute pneumonia [3] and
the risk of pneumonia is greatly enhanced under conditions of impaired pulmonary host
defense, including preceding viral infections [4], mechanical ventilation [5] and sepsis [6]. The
leading causative pathogen of community acquired pneumonia (CAP) is the Gram-positive
bacterium Streptococcus (S.) pneumoniae [7, 8] which accounts for the majority of bacterial
upper and lower respiratory tract infections and is responsible for millions of deaths annually
[9, 10]. As another cause of CAP influenza A virus (IAV) infection leads to rapid progression
of lung failure with limited treatment options and frequent fatal outcome [3, 11, 12]. More-
over, IAV infections are commonly complicated by bacterial superinfection, mostly caused by
S. pneumoniae, resulting in severe progressive pneumonia associated with increased mortality
[13]. In contrast, the Gram-negative and facultatively intracellular bacterium Legionella (L.)
pneumophila is the causative agent of the severe CAP Legionnaires’ disease, and the second
most commonly detected pathogen in pneumonia in patients admitted to intensive care units
(ICU) in industrialized countries [14, 15]. However, in addition to CAP, ventilator-associated
pneumonia (VAP) is also a major cause of hospital morbidity and mortality in ICUs [16] and
the spectrum of pathogens is shifted in these forms of pneumonia. Here Staphylococcus (S.)
aureus, Klebsiella (K.) pneumoniae, Acinetobacter (A.) baumannii, and Escherichia (E.) coli
have been isolated with varying prevalences [17–19]. More specifically, the Gram-negative K.
pneumoniae is a significant opportunistic pathogen causing severe life-threatening hospital-
acquired respiratory tract infections [20–22] while S. aureus, a Gram-positive bacterium, is
one of the most prevalent pathogens of community- and hospital-acquired lower respiratory
tract infections in humans and accounts for a significant health and economic burden [23–25].
A. baumannii and E. coli are ubiquitous Gram-negative bacteria which have recently emerged
as major causes of community-associated, nosocomial [26, 27] and ventilator-associated pneu-
monia [19, 28] as well as septicemia induced acute lung injury (ALI) [29, 30].
In addition, more recently discovered pulmonary pathogens indicate that novel emerging
diseases may add to the list of highly relevant pneumonias that may also be of interest to be
studied in animal models. For example, the Middle East respiratory syndrome coronavirus
(MERS-CoV) which is transmitted by dromedary camels as vectors [31] has emerged as the
cause of severe human respiratory disease worldwide [32, 33] with elderly and immunocom-
promised individuals particularly in Saudi Arabia being at highest risk [34–36].
The various forms of pneumonia have been successfully reproduced in specific murine
models of experimentally-induced acute pneumonia [37–39]. These models have substantially
contributed to our understanding of the pathogenesis of community- and hospital-acquired
pneumonia as well as emerging lung infections worldwide and are indispensable for the devel-
opment of novel therapeutic strategies [40–42].
Histopathology has been a powerful, reliable, and reproducible read-out tool for the evalua-
tion of morphological changes in animal lung infection experiments for many decades [43,
44]. Qualitative diagnoses are based on a summation of microscopically observable changes in
the morphology and cellular composition of the tissue and cell types involved. For a more
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comparative inclusion of histopathologic information in biomedical research, scoring systems
have been widely applied which allow for a first semiquantitative assessment of lesions com-
pared to controls [44, 45]. Moreover, all preclinical models used for the development of novel
treatment strategies and acceptance by regulatory agencies need to be assessed histopathologi-
cally by board certified pathologists as gold standard for qualitative and semiquantitative eval-
uation of tissue alterations in experimental animals [46–48].
Previous studies have revealed first fundamental differences in histopathologic lesions
caused by different pathogens in mouse lungs [38, 41, 42]. However, scoring schemes for acute
murine pneumonia existing to date are very superficial, addressing only a few, rather unspe-
cific parameters [45, 49, 50]. More importantly, they hardly allow for a differentiating perspec-
tive between distinct pathogens or for group comparisons, e.g., infections of wild type versus
genetically modified mice. Clearly, there is a strong need for more precise and pathogen- as
well as model-specific parameters to allow for an accurate description and semiquantification
of the inflammatory phenotype for reliable and reproducible comparisons between experimen-
tal groups within each model. Therefore, we have recently adapted more specific scoring crite-
ria for S. pneumoniae and S. aureus-induced pneumonia [38, 42]. However, such pathogen-
specific scoring criteria have not been employed for other lung pathogens in mice.
Here, we systematically describe and compare the histopathologies at their peaks of inflamma-
tion and injury of nine previously established acute lung infection models induced by S. pneumo-
niae, S. aureus, K. pneumoniae, A. baumannii, L. pneumophila, E. coli, MERS-CoV, IAV and
superinfection with IAV and pneumococci. We provide model-specific criteria that can be used
for appropriate histological quantitative comparisons, e.g., when different therapeutic interven-
tions are evaluated within these established models. Whole mouse lung sections were used to
obtain complete overviews, particularly of the distributions of lesions and inflammatory patterns.
On the basis of the different and oftentimes quite pathogen- and model-specific changes we iden-
tified the most suitable evaluation criteria for each model that will allow for more accurate semi-
quantitative assessments of the severities and distributions of pneumonic lesions.
Materials and methods
Ethics statement
The lung tissues examined here were derived from experiments primarily conducted for pur-
poses other than this study and most have been published elsewhere [38, 41, 42, 51–53], except
for the A. baumannii and E. coli experiments that will be published elsewhere. All animal pro-
cedures and protocols were approved by institutional ethics committees of Charite´-University
of Berlin, Justus-Liebig University of Giessen, Philipps University of Marburg, University Hos-
pital of Jena and local governmental authorities (Landesamt fu¨r Gesundheit und Soziales
(LAGeSo) Berlin, Regierungspra¨sidium (RP) Gießen and Darmstadt, Landesamt fu¨r Verbrau-
cherschutz (TLV) Thu¨ringen), respectively. Permit numbers were G 0356/10, A-0050/15 (S.
pneumoniae), G 0358/11 (S. aureus), G 75/2011, G 110/2014 (K. pneumoniae), A 0299/15 (A.
baumannii), G 0175/12 (L. pneumophila), 02-049/12 (E. coli), 114/2012 (MERS-CoV), G 0152/
12, and G 0044/11 (IAV and superinfection). All animal studies were conducted in strict accor-
dance with the Federation of European Laboratory Animal Science Associations (FELASA)
guidelines and recommendations for the care and use of laboratory animals, and all efforts
were made to minimize animal discomfort and suffering.
All mice, except for MERS-CoV infected mice, were monitored at 12 hour intervals
throughout the experiment to assess appearance, behavior, grooming, respiration, body
weight, and rectal temperature. Humane endpoints were defined (body temperature <30˚C,
body weight loss = 20%, cumbersome breathing, accelerated breathing in combination with
Comparative histopathology of mouse models of acute pneumonia
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staggering, pain or paleness) but not reached by any of the mice at the indicated time points of
termination of the experiments. MERS-CoV infected mice were monitored once daily and
appearance, behavior, grooming, respiration and body weight were protocolled. Here, a single
humane endpoint (loss of body weight of>15%) was defined but not reached by any of the
mice employed due to their favourable clinical outcome at the infection dose used.
Mice
For all experimental infection models, except of K. pneumoniae, female mice (aged 8–12 weeks
and weighing 17–22 g) were randomly assigned to groups (n = 2–4) per cage whereas in the K.
pneumoniae model female and male mice (aged 23–25 weeks and weighing 22–24 g) were used
for model specific reasons [41]. Furthermore, for all experimental infection models, specific-
pathogen-free (SPF) mice on C57BL/6 (all except for MERS-CoV) or BALB/c (as previously
used for the MERS-CoV model [52, 54]) background were used and housed in individually
ventilated cages under SPF conditions with a room temperature of 22 ± 2˚C and a relative
humidity of 55 ± 10%. A 12 hour light/ 12 hour dark cycle was maintained and the animals
had unlimited access to standard pellet food and tap water. All experimental details of the
infection models compared here were applied following previously published and well estab-
lished protocols that partly vary in terms of infection doses, routes of infection and time point
of examination due to pathogen- or model specific reasons, as given below.
For bacterial infections, except for E. coli, mice were anesthetized intraperitoneally with
ketamine (80 mg/kg) (Ketavet; Pfizer, Berlin, Germany) and xylazine (25 mg/kg) (Rompun;
Bayer, Leverkusen, Germany). For experimental viral infections, mice were anesthetized using
inhalation of isoflurane (Forene; Abbott, Wiesbaden, Germany). For lung histology, all mice
except of the MERS-CoV model were humanely euthanized by exsanguination via the caudal
Vena cava after anesthesia by intraperitoneal injection of premixed ketamine (160 mg/kg) and
xylazine (75 mg/kg). MERS-CoV infected mice were humanely euthanized by cervical disloca-
tion after isoflurane anesthesia.
Bacterial infections
S. pneumoniae (serotype 3 strain, NCTC 7978), S. aureus Newman (NCTC 10833), K. pneumo-
niae (serotype 2, ATCC 43816), A. baumannii (RUH 2037), L. pneumophila (serogroup 1 strain,
JR 32) were cultured as described [37, 38, 40, 55, 56] and resuspended in sterile PBS. Mice were
anesthetized intraperitoneally (i.p.) with ketamine (80 mg/kg) and xylazine (25 mg/kg) and trans-
nasally inoculated with 5 x 106 CFU S. pneumoniae (n = 14 mice), 5 x 107 CFU S. aureus (n = 4), 5
x 108 CFU A. baumannii (n = 8), in 20 μl PBS. Mice transnasally infected with L. pneumophila
(n = 8) received 1 × 106 CFU in 40 μl PBS. Mice infected with K. pneumoniae (n = 16) received
3.5 x 105 CFU intratracheally in 50 μl NaCl (0.9%) via Microsprayer1 Aerosolizer (Model IA-1b,
Penn-Century, Inc., Wyndmoor, PA) using intubation-mediated intratracheal instillation through
intact airways [57] which has previously been optimized for this model [41, 57–59].
E. coli (ATCC 25922) from -80˚C glycerol stock was added to LB broth (Carl Roth, Karls-
ruhe, Germany) and incubated for 12 hours at 200 rpm and 37˚C with 5% CO2. Optical den-
sity of 0.03 was adjusted in LB broth followed by incubation until midlogarithmic phase for 1.5
hours at 200 rpm and 37˚C. After centrifugation, the pellet was resuspended in sterile 0.9%
NaCl at 8 x 105 CFU E. coli / 200 μl and administered intraperitoneally (n = 10).
Viral infections and superinfection
For initial transduction of human DPP4 for subsequent infection of BALB/c mice with
MERS-CoV (hCoV EMC) viruses were cultured and prepared as described [52, 54, 60]. Mice
Comparative histopathology of mouse models of acute pneumonia
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were transduced transnasally with 20 μl of an adenovirus vector encoding human DPP4 and
mCherry with a final titer of 2.5 x 108 PFU per inoculum (AdV-hDPP4; ViraQuest Inc.),
resulting in hDPP4 expression in the epithelial compartment of the lung [60] and transnasally
infected with a final titer of 7 x 104 TCID50 of MERS-CoV in 20 μl DMEM (n = 17) under iso-
flurane anesthesia (Forene; Abbott, Wiesbaden, Germany).
Influenza A/PR/8/34 virus (H1N1; PR8) was grown as described [42] and mice were trans-
nasally infected with 100 PFU PR8 in 50 μl PBS (n = 4) under isoflurane anesthesia.
For superinfection experiments, the IAV infection procedure was applied as described
above with 40 PFU PR8 in 50 μl PBS. 8 days after viral infection, S. pneumoniae was cultured
as described [37] and resuspended in sterile PBS. Mice were anesthetized intraperitoneally and
transnasally inoculated with 1 x 103 CFU S. pneumoniae in 20 μl PBS (n = 4).
Histopathology
Mice were humanely euthanized at model-specific time points as indicated (Table 1). Between 2
and 6 repetitions of the entire experimental procedures were performed in each model with
similar group sizes in each repetition. Lungs were carefully removed after ligation of the trachea
to prevent alveolar collapse, immersion-fixed in formalin pH 7.0 for 24 to 48 hours (MERS-CoV
for 7 days), embedded in paraffin, cut in 2 μm sections and stained with hematoxylin and eosin
(HE) after dewaxing in xylene and rehydration in decreasing ethanol concentrations. Bacteria
were visualized using the Giemsa and Gram (modified by Brown and Brenn) stains. For the dis-
play of whole lung overviews, HE stained slides of entire lung sections were automatically digi-
tized using the Aperio CS2 slide scanner (Leica Biosystems Imaging Inc., CA, USA) and image
files were generated using the Image Scope Software (Leica Biosystems Imaging Inc.).
Three evenly distributed whole-organ horizontal sections throughout the entire lungs were
microscopically evaluated to assess the distribution and character of pathologic alterations,
generating a modified panel of specific lung inflammation parameters adapted to each patho-
gen used (Table 1 and Table 2). All examinations were performed by trained veterinary experi-
mental pathologists.
Immunohistochemistry
For immunohistochemical detection of S. pneumoniae and IAV (H1N1), antigen retrieval was
performed with microwave heating (600 W) in 10 mM citric acid (750 ml, pH 6.0) for 12 min-
utes (min). Lung sections were then incubated with a purified rabbit antibody polyclonal to S.
pneumoniae (1:2,000, kindly provided by S. Hammerschmidt) or with a purified goat antibody
polyclonal to IAV H1N1 (1:4,000, OBT155, Bio-Rad, Puchheim, Germany) at 4˚C overnight.
Incubation with an immuno-purified rabbit or goat antibody at the same dilution served as
negative controls. Subsequently, slides were incubated with a secondary, alkaline phosphatase-
conjugated goat anti-rabbit (1:500, AP-1000, Vector, Burlingame, CA) antibody for 30 min at
room temperature. The alkaline chromogen triamino-tritolyl-methanechloride (Neufuchsin)
was used as phosphatase substrate for color development. All slides were counterstained with
hematoxylin, dehydrated through graded ethanols, cleared in xylene and coverslipped.
Results
S. pneumoniae
Transnasal infection of mice with S. pneumoniae, serotype 3 resulted in a broad spectrum of
tissue lesions and immune cell infiltrations that are typical of aerogenic bacterial pneumonia.
Specific for this model, lesions widely expanded down to the periphery of the lung lobes (Fig
Comparative histopathology of mouse models of acute pneumonia
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1A) with inflammation closely surrounding the airways and blood vessels. Pneumococcal
spread led to an early immune response which was mainly characterized by predominantly
intrabronchial (Fig 1B) and intraalveolar (Fig 1C) infiltrations of neutrophils provoking a lob-
ular, suppurative bronchopneumonia with consolidation of affected lung areas. Large areas of
coagulation and liquefaction necrosis (Fig 1D, arrowhead) as indicated by cellular fragmenta-
tion, decay, and loss of cellular details, accumulation of cellular and karyorrhectic debris as
well as karyorrhexis, karyopyknosis, and karyolysis with consecutive hemorrhage were also
present. The perivascular interstitium was widely expanded by edema due to vascular leakage
[53] with massive extravasation of neutrophils recruited into perivascular spaces (Fig 1E). Fur-
thermore, suppurative and necrotizing vasculitis accompanied by hyaline thrombi within
small-sized blood vessels were occasionally present, indicating early histological evidence of
incipient septicemia. Increased pulmonary vascular permeability [53] also led to expanded
areas of protein-rich alveolar edema which presented as homogenous, lightly pink material
Table 2. Pathogen and model-specific presence of lesion patterns in mouse models of acute pneumonia.
Evaluation criteria S. pneumo-
niae






E. coli MERS-CoV IAV IAV +
S. pneumo-
niae
Expansion to peripheral lung
regions
++ - ++ ++ - diffuse ++ ++ ++
Pulmonary atelectasis ++ ++ + ++ - - + + ++
Peribronchial inflammation ++ + + + + - + ++ ++
Perivascular inflammation ++ + + + + + + + ++
Interstitial inflammation + + + + ++ ++ ++ ++ ++
Intraalveolar inflammation ++ ++ ++ ++ + - + + ++
Bronchial epithelial cell necrosis + + + + - - + ++ ++
Alveolar wall necrosis ++ + + + + + ++ ++ ++
Infiltration by neutrophils ++ ++ ++ ++ + ++ ++ + ++
Infiltration by macrophages + ++ + + ++ - ++ ++ +
Infiltration by lymphocytes - + - - + - ++ ++ ++
Abscess formation - ++ ++ + - - - - -
Granuloma formation - - - - ++ - - - -
Alveolar edema ++ + ++ + - - + ++ ++
Perivascular edema ++ - ++ + + - - + +
Perivascular lymphocytic cuffing - ++ - + ++ - ++ ++ +
Hyperplasia of type II alveolar
epithelial cells
- - - - - - + ++ +
Vasculitis ++ - + - + + ++ - +
Fibrinoid degeneration of
vascular walls
- - - - - - ++ - -
Vascular thrombosis +/- - - ++ - ++ ++ - -
Hemorrhage (interstitial,
intraalveolar)
++ + + + - - ++ + +
Pleuritis ++ - ++ - - - - - ++
Steatitis of mediastinal adipose
tissue















-, absent; +, minor; ++, major
* HE, Hematoxylin and Eosin; Gr, Gram; Gi, Giemsa stain; IHC, immunohistochemistry
https://doi.org/10.1371/journal.pone.0188251.t002
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within the alveolar spaces in the HE stain (Fig 1F, asterisk). A distinctive histopathological fea-
ture of pneumococcal pneumonia was the occurrence of massive suppurative to necrotizing
pleuritis (Fig 1G, arrowhead) and steatitis (Fig 1H) with widespread dispersion of bacteria into
the thoracic cavity, likely accounting for the painful and morbid clinical behavior with rapid
progression in affected mice. Myriads of pneumococci were clearly visible as bluish to purple
dots of approximately 1 μm in size in the standard HE stain, mostly located on the pleural sur-
face, in the mediastinal adipose tissue or within perivascular spaces in the lungs.
S. aureus
In contrast, transnasal infection with S. aureus resulted in multifocally extensive but non-expan-
sive bronchopneumonia predominantly located near the lung hilus (Fig 2A), affecting the bron-
chi, alveoli and interstitium. The main inflammatory cell population consisted of neutrophils,
leading to mainly suppurative (Fig 2B and 2C) lesions with a tendency towards abscess forma-
tion. In contrast to pneumococci, macrophages were also present albeit at lower numbers than
neutrophils. (Fig 2C). Similar to Klebsiella and streptococci, large areas of necrosis and hemor-
rhage (Fig 2D) were present. The perivascular areas were predominantly infiltrated by lympho-
cytes and fewer neutrophils (Fig 2E). Compared to the S. pneumoniae model mentioned above
[53], vascular permeability seemed only slightly increased as reported before [38] and perivascu-
lar edema (Fig 2E) as well as protein-rich alveolar edema (Fig 2F, asterisk) were also present
albeit to a lesser extent. Neither pleuritis nor steatitis were observed consistent with a rather
favorable clinical outcome under the conditions used. Furthermore, staphylococci were largely
undetectable by HE stain which was possibly due to the low bacterial spread within the lungs.
K. pneumoniae
Intratracheal infection of mice with K. pneumoniae resulted in severe widely expansive bron-
chopneumonia with increased lesion severity in the lung periphery (Fig 3A). Recruited
Fig 1. Infection with S. pneumoniae. (A—H) Lung histology of mice after transnasal infection with S. pneumoniae (5 x 106 CFU/ mouse)
revealed widely expansive (A), suppurative to necrotizing bronchopneumonia (a-d), predominantly infiltrated by neutrophils within bronchial
lumina (B) and alveoli (C) and large areas of necrosis and hemorrhage (D, arrowhead). Additional features included marked neutrophilic
infiltration and edema of perivascular spaces (E), severe alveolar edema (F, asterisk) and necropurulent pleuritis (G, arrowhead) and
steatitis (H). (A—H) Representative images are shown. Bars (A), 1 mm; (B—D, F—H), 20 μm; (E), 50 μm.
https://doi.org/10.1371/journal.pone.0188251.g001
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immune cells predominantly consisted of neutrophils, leading to suppurative (Fig 3B) to
abscessing (Fig 3C) bronchopneumonia with hemorrhage and necrosis as well as neutrophilic
interstitial pneumonia (Fig 3D) in less affected areas. Increased vascular permeability as
reported [40] was associated with massive alveolar (Fig 3D, asterisk) and perivascular edema
(Fig 3E), admixed with myriads of bacteria easily recognizable as purple dots in the HE stain.
Suppurative to necrotizing vasculitis, pleuritis (Fig 3F, arrowhead), and steatitis were also pres-
ent and associated with marked bacterial spread and the rapid lethal clinical outcome.
A. baumannii
After transnasal infection with A. baumannii, mice developed a widely expansive (Fig 4A)
bronchopneumonia with predominantly infiltrating neutrophils causing a suppurative (Fig
4B) to abscessing inflammation with areas of hemorrhage within alveoli and interstitium and
large areas of parenchymal necrosis as well as alveolar edema. Perivascular spaces had mild to
moderate edema and infiltration of lymphocytes and neutrophils (Fig 4C). Vascular thrombo-
sis was a common change (Fig 4D, arrowhead) in small-sized blood vessels. Similar to staphy-
lococci, Acinetobacter was invisible by HE stain and neither pleuritis nor steatitis were present.
L. pneumophila
Transnasal infection of mice with L. pneumophila resulted in slightly different lesion patterns
depending on the time point of examination after infection. At 48 hours after infection, non-
expansive interstitial pneumonia was found in close proximity to the hilus (Fig 5A) with
Fig 2. Infection with S. aureus. (A—F) Transnasal infection of mice with S. aureus (5 x 107 CFU/ mouse)
resulted in non-expansive (A), suppurative (B, C) to necrotizing (D) bronchopneumonia with infiltration of
neutrophils and lymphocytes into perivascular spaces (E) and protein-rich alveolar edema (F, asterisk). (A–F)
Representative images are shown. Bars (A), 1 mm; (C, D, F), 20 μm; (B, E), 50 μm.
https://doi.org/10.1371/journal.pone.0188251.g002
Comparative histopathology of mouse models of acute pneumonia
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Fig 3. Infection with K. pneumoniae. (A—F) Intratracheal infection of mice with K. pneumoniae (3.5 x 105
CFU/ mouse) resulted in expansive (A), suppurative (B) to abscessing (C) bronchopneumonia as well as
neutrophilic interstitial pneumonia (D) with severe alveolar (D, asterisk) and perivascular (E) edema, massive
fibrinopurulent and necrotizing pleuritis (F, arrowhead) and steatitis. (A–F) Representative images are shown.
Bars (A), 1 mm; (B, D, F), 20 μm; (E), 50 μm; (C), 100 μm.
https://doi.org/10.1371/journal.pone.0188251.g003
Fig 4. Infection with A. baumannii. (A—D) Lung histology of mice after transnasal infection with A. baumannii
(5 x 108 CFU/ mouse) revealed expansive (A), suppurative (B) to abscessing bronchopneumonia with
perivascular inflammation and edema (C) and vascular thrombosis (D, arrowhead). (A—D) Representative
images are shown. Bar (A), 1 mm; (C, D), 20 μm; (B), 50 μm.
https://doi.org/10.1371/journal.pone.0188251.g004
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prominent alveolar wall necrosis (Fig 5B). At the 6 day-time point, specifically the numbers of
infiltrating macrophages were clearly increased, leading to accentuated perivascular granu-
loma formation (Fig 5C, arrowhead). Here, marked lymphocytic cuffing of most blood vessels
as well as highly activated endothelial cells (Fig 5D, arrowhead) were observed. At both time
points, neither pleuritis nor steatitis were present. Bacteria were invisible in the HE stained
sections.
E. coli
After intraperitoneal infection, the hematogeneous spread of E. coli to the lungs had resulted
in diffuse, interstitial suppurative pneumonia, diffusely affecting the entire lungs, modelling
sepsis-induced ALI (Fig 6A). The interalveolar interstitium was heavily infiltrated with neutro-
phils (Fig 6B) with most prominent aggregation around blood vessels (Fig 6C), consistent with
bacterial entry via the circulation. Numerous hyaline thrombi were present within small-sized
blood vessels (Fig 6D, arrowhead), suggestive of disseminated intravascular coagulopathy
(DIC) due to bacterial septicemia. Large, rod-shaped bacteria were easily detectable only out-
side the lungs, mostly present in the adipose tissue surrounding the esophagus, possibly due to
local spread of E. coli via the abdominal cavity.
MERS-coronavirus
Transnasal infection with MERS-CoV following adenoviral transduction of human DPP4
yielded an expansive, (Fig 7A) interstitial pneumonia with severe alveolar epithelial cell necro-
sis and infiltration of mainly macrophages, lymphocytes, and fewer neutrophils (Fig 7B). Only
Fig 5. Infection with L. pneumophila. (A—D) At 48 hours and 6 days post transnasal infection with L.
pneumophila (1 x 106 CFU/mouse), mice developed non-expansive (A), necrotizing to histiocytic interstitial
pneumonia (B) with granuloma formation around blood vessels (C, arrowhead) and prominent lymphocytic
perivascular cuffing with highly activated endothelial cells (D, arrowhead) at the 6 day-time point. (A—D)
Representative images are shown. Bar (A), 1 mm; (B—D), 20 μm.
https://doi.org/10.1371/journal.pone.0188251.g005
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moderate peribronchial (Fig 7C) and perivascular (Fig 7D) lymphocytic infiltrations were
present while most venous blood vessels had marked fibrinoid degeneration and necrosis of
Fig 6. Infection with E. coli. (A—D) Following intraperitoneal infection with E. coli (5 x 108 CFU/ mouse),
mice developed diffuse (A), neutrophilic interstitial (B) and perivascularly accentuated (C) pneumonia with
marked vascular thrombosis (D, arrowhead). (A—D) Representative images are shown. Bar (A), 1 mm; (B—
D), 20 μm.
https://doi.org/10.1371/journal.pone.0188251.g006
Fig 7. MERS-coronavirus. (A—F) Transnasal infection with MERS-CoV (7 x 104 TCID50/ mouse) resulted in
expansive (A), necrotizing, mixed-cellular bronchointerstitial pneumonia (B) with peribronchial and
perivascular infiltration of lymphocytes (C, D), marked fibrinoid degeneration of blood vessels (D, asterisk),
alveolar edema (E, arrowhead) and hemorrhage (F, arrowhead). (A–F) Representative images are shown.
Bar (A), 1 mm; (B, C, E, F), 20 μm; (D), 50 μm.
https://doi.org/10.1371/journal.pone.0188251.g007
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vascular walls (Fig 7D, asterisk). Additional hallmarks of MERS-CoV infection were large
areas of protein-rich alveolar edema (Fig 7E, arrowhead), pronounced hemorrhage within
perivascular and alveolar spaces, and interstitium (Fig 7F, arrowhead), and the formation of
hyaline thrombi within small-sized blood vessels.
Influenza A virus
After transnasal infection with IAV, mouse lungs displayed a diffusely distributed bronchoin-
terstitial pneumonia restricted to single lung lobes only (Fig 8A). Alveolar necrosis was promi-
nent and alveolar septae were diffusely distended by infiltrating inflammatory cells (Fig 8B).
Bronchial epithelial cells were markedly necrotic (Fig 8C, arrowhead) and extensively scaled
off into the bronchial lumen. Alveoli and interstitium were filled with macrophages and lym-
phocytes as major effector cells (Fig 8D) and prominent perivascular lymphocytic cuffing (Fig
8E) was a characteristic change. Furthermore, large areas of alveolar edema (Fig 8F, asterisk)
and, albeit to a much lesser extent, areas of hemorrhage within alveoli and interstitium were
present, suggesting vascular damage and increased permeability.
Superinfection of influenza A virus pneumonia with S. pneumoniae
When mice had been infected with IAV prior to infection with S. pneumoniae, a combination
and exponentiated phenotype of both models was observed 24 hours later. Lesions were widely
expansive to the lung periphery but restricted to single lung lobes pre-damaged by IAV (Fig
9A). The character of pneumonia included massive infiltration of neutrophils into alveoli
(Fig 9B) and bronchi, typical features of severe, suppurative bronchopneumonia. Bronchial
epithelium was almost entirely necrotic and bronchi were filled up with pus (Fig 9C). Peri-
vascular spaces were edematous and infiltrated by neutrophils and lymphocytes (Fig 9D)
whereas only mild lymphocytic perivascular cuffing (Fig 9E) was present. A severe protein-
rich alveolar edema was seen, similar to that seen in the S. pneumoniae mono-infection (Fig
Fig 8. Influenza A virus. (A–F) After transnasal infection, IAV (100 PFU/ mouse) resulted in diffuse (A),
necrotizing (B), bronchointerstitial pneumonia (B, C) with marked necrosis and sloughing of bronchial
epithelial cells (C, arrowhead), lympho-histiocytic intraalveolar and interalveolar interstitial infiltration (D),
prominent perivascular cuffing of lymphocytes (E) and protein-rich alveolar edema (F, asterisk). (A–F)
Representative images are shown. Bar (A), 1 mm; (B—D, F), 20 μm; (E), 50 μm.
https://doi.org/10.1371/journal.pone.0188251.g008
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9F). Pneumococci were difficult to visualize by HE stain, possibly due to the lower infectious
dose used here when compared to the mono-infection.
Distributions, expansions and symmetry
Prior to processing for histopathology, small tissue samples from experimentally infected
mouse lungs are commonly removed for molecular analyses of gene and/ or protein expression
or other readout systems to receive additional information. To obtain representative data from
such samples that can be correlated with the histological changes, it is crucial to know about
the homogeneity of the distribution of lesions. Also, some experimental protocols recommend
to use the left and right halves of the lungs, respectively, for different analytical procedures,
again anticipating lesion homogeneity and symmetry. However, when we analyzed the distri-
butions and bilateral symmetry of lung lesions for each of the infection models, we found a
wide spectrum of distinct distributions and asymmetries (Fig 10). In principle, lesion distribu-
tions followed the route of pathogen entry into the lungs. However, the tendencies to spread
towards the periphery of the lobes after aerogenous infection varied between different patho-
gens despite similar aerogenous infection routes. Mostly centrally focused lesions induced by
S. aureus and L. pneumophila remained close to the hilus with no trend towards peripheral
expansion. Infection with S. pneumoniae, A. baumannii and MERS-CoV resulted in lesions
closely surrounding major airway segments with centrifugal expansion towards the periphery.
In contrast, lesions induced by K. pneumoniae were mostly located in the periphery of the
lobes and airways and much weaker adjacent to the hilus despite aerogenous infection. Hema-
togenously-induced sepsis with E. coli was associated with an entirely diffuse distribution of
lesions affecting the whole lung with myriads of inflammatory hot spots, commonly surround-
ing blood vessels. IAV-induced lesions were restricted to individual lung lobes only with a
rather homogeneous distribution within affected lobes. Superinfection of S. pneumoniae into
an IAV-pneumonia resulted in a pattern virtually identical to that seen after IAV infection
Fig 9. Superinfection of influenza A virus pneumonia and S. pneumoniae. (A–F) Superinfection with S.
pneumoniae (1 x 103 CFU/ mouse) of mice that had been infected with IAV (40 PFU/ mouse) earlier resulted
in severe expansive (A), suppurative bronchopneumonia (B) with marked necrosis of bronchi which were filled
up with pus (C). In addition, perivascular infiltration of neutrophils, lymphocytes and monocytes with
prominent edema (D) as well as mild purely lymphocytic, dense perivascular cuffing in other areas (E) and
protein-rich alveolar edema (F, asterisk) were present. (A–F) Representative images are shown. Bars (A), 1
mm; (B—F), 20 μm.
https://doi.org/10.1371/journal.pone.0188251.g009
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alone. Except for blood borne E. coli pneumonia which was consistently and evenly distributed
throughout the entire lungs, affected areas in all other models tested here were randomly dis-
tributed more or less asymmetrically between the right and left halves of the lungs and also
between adjacent lobes (Fig 10).
Visualization of pathogens using special stains and
immunohistochemistry
For more than 100 years, a wide range of special stains have been used for the histological
visualization of pathogens and other relevant structures, based on their more or less specific
affinities to certain dyes. Here, Gram stain modified by Brown and Brenn was used for the
visualization of Gram-positive bacteria, including S. pneumoniae (Fig 11A, arrowhead), as eas-
ily recognizable, dark blue cocci. In contrast, Giemsa stain was conducted predominantly for
the detection of Gram-negative bacteria such as K. pneumoniae (Fig 11B, arrowhead) which
then turned into light blue to greenish rods.
For more specific pathogen detection on slides, particularly for viruses, immunohisto-
chemistry is the method of choice. Here, S. pneumoniae and IAV were detected by immuno-
histochemistry using specific anti-S. pneumoniae or anti-IAV antibodies, respectively. S.
pneumoniae-positive signals were obtained as myriads of red cocci predominantly in the peri-
vascular interstitium (Fig 11C), within neutrophils in alveoli and interstitium, and on pleural
surfaces as well as in mediastinal adipose tissue. In addition, pneumococci were also visualized
in the marginal sinuses of tracheal lymph nodes, both in macrophages and extracellularly. IAV
antigen was localized to the apical surface and cytosol of intact and necrotic bronchial epithe-
lial cells (Fig 11D) and within alveolar macrophages.
Selection of criteria suitable for scoring systems for each pathogen
The diversity of lesions and in particular the presence or absence of specific patterns in several
of the models used (Table 1) strongly suggested that a uniform scoring scheme for the
Fig 10. Distributions, expansions and symmetries of affected lung parenchyma. Infection of murine lungs with different bacterial or viral
pathogens resulted in striking differences in the distributions, expansions and symmetries of pneumonic lesions that were highly reproducible
for each pathogen. Mainly centrally located lesions induced by S. aureus and L. pneumophila remained close to the hilus with no trend towards
peripheral expansion. Infection with S. pneumoniae, A. baumannii and MERS-CoV resulted in lesions closely surrounding the airways and
blood vessels close to the central major airway segments with centrifugal expansion towards the periphery. In contrast, lesions induced by K.
pneumoniae were mostly located in the periphery of the lobes and airways and much weaker adjacent to the hilus. Hematogenous infection
with E. coli was associated with entirely diffuse distribution of lesions affecting the whole lungs with myriads of inflammatory hot spots,
commonly surrounding blood vessels. IAV-induced lesions were restricted to individual lung lobes with a rather homogeneous distribution
within affected lobes. Which lobes were affected followed a rather random and inconsistent pattern. Superinfection of S. pneumoniae into an
IAV-pneumonia resulted in a pattern virtually identical to that seen after IAV infection alone. Except for E. coli induced pneumonia, virtually all
lung lesions were distributed asymmetrically between the left and right lung halves with no tendency of either half to be more often or more
strongly affected.
https://doi.org/10.1371/journal.pone.0188251.g010
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semiquantification of mouse pneumonia is inconceivable. Instead, scoring systems should take
into account the more or less pathogen-specific lesion patterns that can be distilled from the
comparative characterizations given above. For this purpose, we carved out the most charac-
teristic lesion patterns that appear suitable for the development of specific scoring schemes for
each model (Table 2).
Discussion
Different mouse models of acute pneumonia differ widely, with an obvious strong dependence
on pathogen-specific features of virulence and spread, route of infection, infectious dose and
other factors. Here, we provide a detailed descriptive overview of histopathological features
and distributions of lesions within infected lungs and compare them between nine relevant
and commonly used infection models at their peaks of injury and inflammation. The models
employed here all represent well established protocols that have been optimized and success-
fully used in previous studies, with model-specific variations in infection doses, routes of path-
ogen administration and analyzed time points [37–42, 51, 52, 54–56]. Our model-specific
description parameters (Table 2) provide a rational for the selection of histopathological quan-
tification criteria, in order to best reflect the model-specific lesion and distribution characteris-
tics, which appear to be most relevant. Clearly, the severity of lesions in terms of outcome of
quantification systems will depend on several other factors that will have to be addressed sepa-
rately in each model, such as the infection dose, time point of examination or therapeutic
interventions.
Fig 11. Visualization of pathogens. Pathogens were visualized using special stains commonly used for
bacterial detection, including the Gram stain for Gram-positive pneumococci (A, dark blue, arrowhead), and
Giemsa stain of Klebsiella (B, light blue, arrowhead). Immunohistochemical staining methods were employed
to localize specific antigens of S. pneumoniae (C, red, arrowhead) and IAV (D, red, arrowhead). Triamino-
tritolyl-methanechloride (Neufuchsin) was used as chromogen (red) and hematoxylin (blue) as counterstain.
Bars (a–d), 20 μm.
https://doi.org/10.1371/journal.pone.0188251.g011
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The model-associated characteristics of tissue lesions and immune cell infiltrates are widely
consistent with well-established properties of the different pathogens used. For example, the
destructive tissue damage with mostly neutrophilic infiltrations as seen in S. pneumoniae, S.
aureus, and A. baumannii, are typically seen with extracellular bacteria that express cytotoxic
virulence factors, such as pneumolysin and hydrogen peroxide [61] from S. pneumoniae or
immunogenic cell wall components such as lipoteichoic acid (LTA) from S. aureus [62, 63]. On
the other hand, the intracellular pathogen L. pneumophila which primarily infects macrophages
[64] resulted in a histiocytic infiltrate at 48 h that developed into granulomatous inflammation
at 6 days after infection, typical of a TH1-response [65, 66]. However, several of the pathogens
used were associated with additional distinctive features. For example, histology revealed
marked pleuritis and steatitis due to pathogen invasion into adjacent extrapulmonary tissues
after infections with S. pneumoniae and K. pneumoniae. This massive bacterial spreading
throughout the thoracic cavity was exclusively present in these two models and most likely asso-
ciated with sepsis, responsible for the rapid clinical progression and unfavourable outcome [41,
67]. However, only K. pneumoniae had the tendency of abscess formation which was not seen in
pneumococcal pneumonia. Infection with S. aureus and A. baumannii also resulted in similar
lesion patterns, except for Acinetobacter-induced lesions widely expanding to the lung periphery
while Staphyloccocus-induced pneumonia was restricted to the lung hilus. A second difference
between the two was the presence of prominent vascular thrombosis in A. baumannii-induced
pneumonia which was absent from Staphylococcus pneumonia. The clinical outcome of mice
infected with A. baumannii and S. aureus was more favourable when compared to infection
with S. pneumoniae or K. pneumoniae [38] which may be explained by the lack of bacterial
spreading throughout the thoracic cavity and adjacent tissues, and possibly sepsis. E. coli infec-
tion was included here as a model for sepsis-associated ALI [29, 30, 68] and consequently
induced wide spread vascular thrombosis and vasculitis, most likely due to its blood borne entry
into the lungs and concurrent septicemia with disseminated intravascular coagulopathy and
associated vascular lesions. Vascular thrombosis with or without vasculitis was also observed in
other models, including S. pneumoniae, A. baumannii and MERS-CoV, however, to a much
lesser extent and only within the most strongly affected areas. MERS-CoV and IAV-associated
lesions clearly reflected the known cellular tropisms of these viruses with necrosis of alveolar
walls or bronchial epithelial cells, respectively, being the most characteristic histopathologic fea-
tures [69–72]. Typical of virally induced lesions, the inflammatory cell infiltrates in MERS-CoV
and IAV infections were dominated by lymphocytes with no or only few neutrophils. Neverthe-
less, the two viral models could be clearly distinguished from each other by additional histologi-
cal characteristics. Only the MERS-CoV infection led to a marked vascular phenotype with
necrosis and degeneration of blood vessels, vasculitis, and consecutive vascular thrombosis as
well as pronounced hemorrhages [69, 73]. In contrast, IAV-induced pneumonia did not display
any of these features, but was dominated by marked perivascular lymphocytic cuffing and alveo-
lar edema [42, 74]. Subsequent superinfection with low-dose S. pneumoniae potentiated the
severity of the IAV-induced lesions and aggravated the course of pneumonia. However, it did
not alter the principal histological characteristics of IAV-pneumonia. The patterns seen after
single infection with S. pneumonia were not repeated in this superinfection model, likely owing
to the much lower inoculation dose which is usually rapidly cleared from virus-naive lungs.
When the distributions of lesions were compared among the 9 models tested, four distinct
patterns could be clearly distinguished. The most common pattern, where lesions were focused
around central airways and blood vessels close to the lung hilus with the periphery less or not
affected can likely be explained by the aerogenous route of infection and pathogen entry. The
opposite pattern characteristic of K. pneumoniae infection where the periphery of the lobes
was more strongly affected than their hilus areas despite a similar aerogenous route of
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infection may be due to the aerosolic intratracheal application [75] of these bacteria which is
typical of and necessary in this model [41, 57–59]. These differences are therefore more likely
attributable to the model-specific route of infection rather than pathogen-specific properties.
Similarly, the very homogenous distribution of E. coli induced pneumonia likely followed the
diffuse blood borne entry of the pathogen into the lungs after intraperitoneal infection. Again
unique among the pathogens tested here, the IAV-associated pattern affected entire but only
select lung lobes with almost complete sparing of others. This distribution probably followed a
random spread of the virus along major airways but why some lobes remained virtually unaf-
fected after transnasal infection remains hard to explain. Apart from helping to understand
differences in pathogen spread, the uneven and often quite asymmetrical distributions have a
tremendous impact in practical terms when acute mouse pneumonia is sampled for molecular
studies. When quantitative data on mRNA or protein expression levels or other biochemical
information are to be compared with one another or with tissue lesions, it is imperative that
only identically affected areas are compared. Since this is impossible to predict or recognize on
the macroscopical level for most models, the practice of sampling different regions of such
lungs for different readout systems appears highly problematic.
Another implication of the distinct lesion characteristics, immune cell reactions and distri-
butions among the different models appears highly relevant for histological scoring systems
that aim at first quantitative comparisons [45]. To narrow down the list of parameters appro-
priate for each pathogen and exclude features that are likely irrelevant for some of the models,
we selected 23 single histopathologic criteria for the design of semiquantitative scoring systems
suitable for each model. These criteria are partly composed of standard parameters such as the
determination of the affected lung area, the distribution of lesions or the type of pneumonia
induced. However, numerous other and more model-specific parameters were identified
which precisely describe particular aspects and allow for a differentiation between the models,
such as the presence of perivascular edema, vascular thrombosis, pleuritis or steatitis. Appro-
priate scoring systems may thus encompass more general parameters when different patho-
gens are compared to one another or more pathogen-specific parameters in case specific
pathogen features are in the focus of an experiment. For example, some of the parameters
selected here have proven helpful in the discovery and semiquantification of different pheno-
types of mouse pneumonia following genetic engineering of pathogens or mice [38, 51, 76].
However, scoring systems that claim universality for all mouse models of acute pneumonia
seem neither generally applicable nor meaningful for all specific experimental goals. Even the
list of 23 parameters selected here may become inappropriate or insufficient when genetic
changes on the pathogen or host side may result in different types of lesions, immune cell
responses, time courses or other relevant features. In those cases, the list selected here may
have to be adjusted or extended to better meet the specific challenges of each new study.
As standard hematoxylin and eosin (HE) staining of tissue sections failed to visualize most
pathogens, traditional special stains as well as immunohistochemical techniques were
employed, depending on specific staining properties of the pathogens and the availability of
appropriate antibodies. While S. pneumoniae, K. pneumoniae and E. coli were easily visible in
HE stained tissue sections in areas with low density of inflammatory cells, e.g., in perivascular
spaces, they were very difficult to identify in heavily infiltrated and consolidated lung paren-
chyma. In contrast, S. aureus, A. baumannii, L. pneumophila and both viruses were entirely
invisible by HE staining and thus had to be visualized by appropriate histotechnical stains or
immunohistochemistry. Both approaches will likely also allow for a rough quantification of
pathogen numbers in tissues when appropriate image analysis tools are used.
In this first comparative study of its kind, we examined previously established models with
their optimized routes of infection, time points, and infection doses and volumes specific for
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each model to reach peaks of lung injury and inflammation. Variations of such factors can be
expected to result in different lesion severities, composition of the cellular infiltrates, and for
some models in different expansions of lesions within the lung. Still, the conditions used here
are all based on observations that have evolved during extensive previous establishment studies
of these models [37–39, 41, 42, 51, 52, 54, 56–58, 60, 77–79]. Among the most important rea-
sons, most human pathogens are not pathogenic for mice under non-experimental conditions
and the decisive factor for obtaining a useful pneumonia model appears to be the determina-
tion of the appropriate infection dose and route of infection. In addition, the exact time points
of tissue analysis after infection had to be determined for virtually all models with care to
obtain a useful model, including a precise definition of the strain or variant of the pathogen
used [51, 53, 80, 81]. Another variable to consider is the mouse strain used. Except for BALB/c
mice which were used in the MERS-CoV infection model here for model-specific reasons [60],
all models were conducted with C57BL/6 mice which is among the most commonly used
mouse strain in infection research and therefore allows for comparisons with similar studies.
However, variations of the strain or genetic background may have a dramatic impact on the
type, severity and outcome of inflammation, particularly in innate immune responses [82–84].
Again, the criteria suggested here for scoring procedures should allow to recognize and quan-
tify such differences related to changes in infection dose and volume, time point of examina-
tion, strain and age of mice used, pathogen variant and other variables.
Histopathology of the lungs may be complex and requires fundamental knowledge in spe-
cies-specific anatomy, physiology, organ-specific immunology, pathology, and histotechnical
procedures. Furthermore, various background lesions in mice, including strain specific spon-
taneous degenerative or inflammatory conditions and the possibility of accidental infections
unrelated to the experiment should not be confused with experimental outcome. Thus, despite
our efforts to specify and simplify the criteria relevant for model-specific assessment and quan-
tification of lesions, it appears crucial that trained histopathology experts be involved in the
microscopical examination of mouse lungs [46, 85].
Clearly, in addition to descriptive or semiquantitative histology, a number of other parameters
may be useful for quantitative comparisons between experimental groups to determine the role of
specific cell types, molecules, and therapeutic interventions, depending on the strategy and goal of
the study [44]. Such parameters could include flow cytometric immune cell identifications and
quantifications, ELISA or quantitative RT-PCR for the probing of cytokines, chemokines or
matrix proteins involved in lung pathology and remodeling, and plaque/colony forming assays
for the identification or quantification of pathogens, as previously published for most of the mod-
els used here [38, 41, 42, 51–53, 86, 87]. All of these methods, however, lack the spatial resolution
that only histological assessments offer. Only the combination of these techniques will lead to a
better understanding of the disease in the complex context of the entire lung pathology.
In conclusion, we have identified a spectrum of pathogen- and model-specific lesion char-
acteristics in mouse models of acute pneumonia. Our findings underscore the necessity of
model-specific criteria for the accurate histopathological characterization and quantitative
assessments of experimental pneumonia. This comparative landscaping of acute mouse pneu-
monia histology provides a comprehensive framework for future studies on the role of individ-
ual pathogen or host factors, complex disease mechanisms, and novel therapeutic strategies
that could help to treat pneumonia in human patients.
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